Skip to main content
Premium Trial:

Request an Annual Quote

Veracyte Amends Loan Agreement

NEW YORK (GenomeWeb) – Veracyte said on Thursday it has amended a loan agreement with Silicon Valley Bank originally forged in June 2013.

Under the terms of the amendment, Veracyte can borrow up to $15 million in three tranches, each tranche not exceeding $5 million. The company borrowed $5 million from the first tranche this week to repay in full the initial $5 million loan drawn in June 2013, the San Francisco-based developer of gene expression-based diagnostic tests said in a document filed with the US Securities and Exchange Commission. 

It can draw on a second tranche of up to $5 million on or before Dec. 31, 2015 and borrow up to another $5 million on or before June 30, 2016.

The firm said that the term loans bear interest at a fixed rate equal to 1.75 percent above the prime rate as published in The Wall Street Journal on the date of incurrence, resulting in the initial $5.0 million term loan bearing interest at a fixed rate of 5 percent.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.